Evergraf 0.25mg Everolimus Tablet Description:
Evergraf 0.25mg Tablet suppresses the activity of the human immune system and prevents rejection of transplanted organ.
Evergraf 0.25mg tablet is used to prevent organ rejection in transplant patients. It regulates the body’s immune response so that the body can accommodate the new organ. It is also used in combination with other medicines to treat breast, pancreatic, lung and kidney cancers.
Weakness, sinusitis, infection, fever, cough, fatigue, stomatitis (inflammation of the mouth), otitis media (infection of the ear), diarrhea, upper respiratory infection, etc.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Evergraf 0.25mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Is Evergraf 0.25mg a chemotherapy medicine?
Evergraf 0.25mg is a cancer medicine. It belongs to the class of kinase inhibitors. It reduces the blood supply to the tumor, which slows the growth and spread of cancer cells.
How long can you take Evergraf 0.25mg?
There is no specific duration of treatment with Evergraf 0.25mg. Evergraf 0.25mg continues to be taken until clinical improvement is evident or unacceptable toxicity or side effects occur.
How do I know if Evergraf 0.25mg reduces my brain tumor?
The effect of the Evergraf 0.25mg on tumor shrinkage can only be verified with regular brain scans. This should be done as recommended by your doctor and your treatment plan.
Is Evergraf 0.25mg cytotoxic?
Yes, Evergraf 0.25mg is cytotoxic to human breast, stomach, prostate and kidney cancer cells (renal cell carcinoma).
Evergraf Everolimus 0.25mg is available in other strength